Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2021 08:19 ET | Source: Biomerica, Inc.

Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test

Digital Health Advertising and Social Media Campaigns launching alongside new siteCurrently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE,...
June 24, 2021 08:19 ET | Source: Biomerica, Inc.

Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™

Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced...
June 15, 2021 08:19 ET | Source: Biomerica, Inc.

Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testing & Treatment

IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% [1] (approximately 20 million patients)Broadens InFoods® global patent coverage with recently...
June 04, 2021 08:00 ET | Source: Biomerica, Inc.

Biomerica to Participate in Upcoming Investor Conferences

IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming...
May 11, 2021 08:19 ET | Source: Biomerica, Inc.

Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

Less invasive nasal swab taken from front opening of the nose is more comfortable for patientsTest can be performed by doctors, school and company nurses, and medical assistants, in any location...
April 15, 2021 10:31 ET | Source: Biomerica, Inc.

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including...
January 15, 2021 09:27 ET | Source: Biomerica, Inc.

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021 FDA actively reviewing Company’s EUA submission for its...
January 12, 2021 08:19 ET | Source: Biomerica, Inc.

Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

Biomerica receives first orders and plans to ship tests in coming weeks Clinical studies demonstrated an overall performance of 94.7% positive agreement (sensitivity) and 99.7% negative agreement...
December 09, 2020 08:19 ET | Source: Biomerica, Inc.

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

Patient enrollment completion anticipated by the end of April 2021InFoods® Diagnostic-Guided Therapy is designed to address the $30 billion market for IBS treatmentTherapy seeks to identify...
October 16, 2020 09:27 ET | Source: Biomerica, Inc.

Biomerica Reports Fiscal 2021 1st Quarter Financial Results

IRVINE, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported financial results for the fiscal quarter ended August...